11 completed, 6 recruiting, 5 unknown. 8 Phase 1, 7 Phase 2, 3 Not applicable, 3 Phase 3, 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Recruiting 5, Completed 3 |
| Phase 2 | 7 | Recruiting 4, Completed 2, Unknown 1 |
| Not applicable | 3 | Unknown 2, Completed 1 |
| Phase 3 | 3 | Completed 3 |
| Phase 4 | 3 | Completed 2, Unknown 1 |
Follow Kyushu University: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study of Sivelestat in Neuromyelitis Optica Spectrum Disorder Sivelestat sodium hydrate - Neuromyelitis Optica Spectrum Disorder Attack | Phase 1 / Phase 2 | Recruiting | Kyushu University | 7 | 2026-10-01 | 2026-10-07 |
| Safety Evaluation Study of Pitavastatin PLGA Nano-particle for Retinitis Pigmentosa ULREA-PVS-NP - Retinitis Pigmentosa (RP) | Phase 1 | Recruiting | Kyushu University | 21 | 2026-10-01 | 2026-10-07 |
| Clinical Trial of AM80 in Combination With Gemcitabine, Cisplatin, and Nivolumab in Patients With Urothelial Carcinoma Add-on effect of adding tamivarotene (AM80) to gemcitabine, cisplatin, and nivolumab combination therapy - Urothelial Carcinoma Bladder, Urothelial Carcinoma of the Renal Pelvis and Ureter | Phase 2 | Recruiting | Nagoya University | 43 | 2025-05-01 | 2025-08-14 |
| Safety Evaluation Study for Patients With Aggressive NK-cell Leukemia PPMX-T003 - Aggressive NK Cell Leukemia | Phase 1 / Phase 2 | Recruiting | Hiroshima University Hospital | 7 | 2023-09-21 | 2025-04-30 |
| Clinical Trial of GAIA-102 for Refractory/Relapse Neuroblastomas and Other Malignant Pediatric Solid Tumors Biological - Refractory/Relapse Neuroblastoma, Pediatric Solid Tumors | Phase 1 | Recruiting | Kyushu University | 61 | 2022-10-26 | 2026-08-07 |
| GAIA-102 Intraperitoneal Administration in Patients With Advanced Gastrointestinal Cancer of Microsatellite Stable With Malignant Ascites GAIA-102, Pembrolizumab, Trifluridine/tipiracil hydrochloride (FTD/TPI) - Gastric Cancer, Pancreatic Cancer | Phase 1 / Phase 2 | Recruiting | Kyushu University | 176 | 2022-06-08 | 2026-09-15 |
| Clinical and Economic Validation of the ISGPS Definition of PPAP PPAP diagnosis - Postoperative Acute Pancreatitis, Pancreaticoduodenectomy | Completed | Azienda Ospedaliera Universitaria Integrata Verona | 2900 | 2022-01-01 | 2024-01-16 | |
| Clinical Trial to Investigate Safety and Efficacy of Edoxaban in Patients With CTEPH (KABUKI) Edoxaban, Warfarin Potassium, Warfarin Potassium placebo - CTEPH | Phase 3 | Completed | Kyushu University | 74 | 2021-03-23 | 2023-10-05 |
| PhaseI/II Investigator-Initiated Trial to Investigate Safety and Efficacy of Ripasudil in Patients With Retinopathy of Prematurity Ripasudil ophthalmic solution 0.4% - Retinopathy of Prematurity | Phase 1 / Phase 2 | Completed | Kyushu University | 24 | 2020-11-01 | 2023-02-06 |
| Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis PRI-724 - Hepatitis C, Hepatitis B | Phase 1 / Phase 2 | Completed | Kiminori Kimura, MD | 27 | 2018-07-24 | 2024-10-10 |
| Long Term Oral Appliance Therapy Effectiveness for Obstructive Sleep Apnea Syndrome Oral Appliance - Obstructive Sleep Apnea | Unknown | University of British Columbia | 1000 | 2018-04-01 | 2024-01-23 | |
| A Study for G1b CHC Patients With CKD-3 Treated With Grazoprevir Plus Elbasvir Grazoprevir plus Elbasvir - Hepatitis C Viral, Chronic Kidney Disease stage3 | Phase 4 | Completed | Kyushu University | 80 | 2017-04-01 | 2019-06-03 |
| To Compare Anti-VEGF Monotherapy With Anti-VEGF and EPM Grid Laser Combination Therapy for Diabetic Macular Edema End-Point-Management grid laser, ranibizumab, Bevacizumab - Diabetic Macula Edema | Phase 4 | Unknown | The University of Hong Kong | 60 | 2015-06-01 | 2016-04-19 |
| Randomized Phase IIb Trial of DVC1-0101 DVC1-0101 - Intermittent Claudication, Peripheral Arterial Disease | Phase 2 | Unknown | Kyushu University | 30 | 2014-10-01 | 2023-10-04 |
| Ranibizumab Treatment for Age-Related Macular Degeneretion Intravitreal Lucentis 0.5mg - Visual Disorder Due to Age-related Macula Degeneration | Not applicable | Unknown | Kyushu University | 100 | 2013-12-01 | 2014-06-09 |
| Pancreatic Juice Diagnosis From Duodenum Tumor markers - Pancreatic Adenocarcinoma | Not applicable | Completed | Olympus Corporation | 105 | 2012-10-01 | 2015-09-21 |
| An Open-label, Single-dose, Two-treatment, Randomized, Cross-over Study to Investigate the Effects of the SLCO2B1 c.1457C>T Polymorphism and Apple Juice on the Pharmacokinetics and Pharmacodynamics of Acebutolol in Healthy Korean and Japanese Volunteers Acebutolol, Placebo - Healthy | Phase 4 | Completed | In-Jin Jang, MD, PhD | 16 | 2012-01-01 | 2012-06-20 |
| Combination Pill of Losartan Potassium and Hydrochlorothiazide for Improvement of Medication Compliance Trial Combination pill of losartan and hydrochlorothiazide - Hypertension | Phase 3 | Completed | Kyushu University | 207 | 2008-06-01 | 2011-03-07 |
| Safety Study of Cancer Specific Epitope Peptides Cocktail for Cervical, GI, and Lung Tumors 5 peptide vaccines of KOC1, TTK, CO16, DEPDC1, MPHOSPH1 - Metastatic Tumors | Phase 1 | Completed | Kyushu University | 18 | 2007-11-01 | 2011-06-23 |
| Cilostazol-Aspirin Therapy Against Recurrent Stroke With Intracranial Artery Stenosis Asprin, Cilostazol - Cerebrovascular Disease | Phase 3 | Completed | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | 200 | 2006-05-01 | 2017-12-19 |
Showing 20 of 22. Sign in to see all of them.
Hepatitis C (3) · Carcinoma, Transitional Cell (1) · Cerebrovascular Disorders (1) · Graves Disease (1) · Hepatitis B (1) · Hyperamylasemia (1) · Hypertension (1) · Intermittent Claudication (1) · Intracranial Arteriosclerosis (1) · Leukemia, Large Granular Lymphocytic (1) · Liver Cirrhosis (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Pancreatic Fistula (1) · Pancreatic Neoplasms (1)
Acebutolol (1) · Bevacizumab (1) · Biological Products (1) · Biomarkers, Tumor (1) · Cilostazol (1) · Cisplatin (1) · DEPDC1 protein, human (1) · Fluorouracil (1) · Hydrochlorothiazide (1) · ICG 001 (1) · KIF20B protein, human (1) · LY6K protein, human (1) · Lactose (1) · Losartan (1) · Potassium Iodide (1)
Japan (18) · Canada (1) · China (1) · Italy (1) · South Korea (1) · United States (1)
Fernanda Almeida, DDS,Phd (1) · Giovanni Marchegiani (1) · Ian Wong, FRCOphth (1) · Jun Hayashi (1) · Kenzaburo Tani, MD,phD (1) · Kiminori Kimura, MD (1) · Kiyoshi Matsumura, MD PhD (1) · Kohtaro Abe (1) · Kyoichi Ohashi, MD, PhD (1) · Massimo Raimondo, M.D. (1) · Mitsuru Arima, MD,PhD (1) · Nobuyuki Sakai, M.D. PhD (1) · Norihiro Furusyo, MD, PhD (1) · Shinichiro Uchiyama, M.D. PhD (1) · Syusuke Akamatsu (1)
PMID 34315793, PMID 35605429, PMID 37070473, PMID 38849479, PMID 40588385